Earnings roundup: Nymox Pharmaceutical 2Q loss widens; Penney posts small loss, beats views
By APFriday, August 14, 2009
Earnings roundup: Nymox Pharmaceutical, Penney
Among the earnings stories for Friday, Aug. 14, from AP Financial News:
NEW YORK (AP) — Canadian biotechnology company Nymox Pharmaceutical Corp. said its second-quarter loss widened on higher costs for a late-stage development program on a treatment for enlarged prostate.
NEW YORK (AP) — J.C. Penney Co. posted a small loss in the second quarter, just topping Wall Street expectations as the department store chain benefits from inventory controls and other cost-cutting moves.
RICHMOND, Calif. (AP) — Drug developer Transcept Pharmaceuticals Inc. said its second-quarter loss widened on higher operating expenses.
NEW YORK (AP) — A chastened Abercrombie & Fitch Co. said it is actively lowering prices and trying to catch up with fashion trends such as dresses as the retailer reported a fiscal second-quarter loss and its third straight quarter of double-digit sales declines.
NEW YORK (AP) — Chinese pharmaceuticals maker China Sky One Medical Inc. said its profit grew 17 percent in the second quarter due to greater sales of ointments, sprays, and testing kits.
